PCN64 - Budget Impact Analysis of Regorafenib for The Treatment in Third and Fourth Lines of Metastasic Colorectal Cancer in Spain

Autor: González Flores, E, Vera García, R, Sabater Cabrera, E, Tirado Mercier, E, Granell Villalon, M

Publikováno v: In Value in Health November 2016 19(7):A719-A720

Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain.

Autor: Tirado Mercier E; Pharmaceuticals Division Bayer Hispania, SL, Barcelona, Spain., Callejo Velasco D; IQVIA, Madrid, Spain., Rubio Cabezas M; IQVIA, Madrid, Spain., Moretones Agut C; Pharmaceuticals Division Bayer Hispania, SL, Barcelona, Spain., Granell Villalón M; Pharmaceuticals Division Bayer Hispania, SL, Barcelona, Spain.

Publikováno v: Journal of health economics and outcomes research [J Health Econ Outcomes Res] 2018 Jan 29; Vol. 6 (1), pp. 1-14. Date of Electronic Publication: 2018 Jan 29 (Print Publication: 2018).